LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 81.20 | 770.25 | 2026 | 11766 | 0.1722 | 0.2788 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 81.20 | 770.25 | 1922 | 11766 | 0.1634 | 0.2617 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 83.42 | 770.25 | 2062 | 12031 | 0.1714 | 0.2819 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 83.42 | 770.25 | 1961 | 12031 | 0.1630 | 0.2658 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 85.64 | 770.25 | 2100 | 12287 | 0.1709 | 0.2853 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 85.64 | 770.25 | 1979 | 12287 | 0.1611 | 0.2664 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.86 | 770.25 | 2151 | 12543 | 0.1715 | 0.2906 | MN20160304_L02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 87.86 | 770.25 | 2031 | 12543 | 0.1619 | 0.2723 | MN20160304_L02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 3.21 | 770.25 | 814 | 904 | 0.8998 | 0.2689 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 3.21 | 770.25 | 985 | 904 | 1.0888 | 1.8865 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 5.44 | 770.25 | 941 | 1012 | 0.9292 | 0.6604 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 5.44 | 770.25 | 1090 | 1012 | 1.0763 | 1.4092 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 7.66 | 770.25 | 1033 | 1090 | 0.9477 | 0.7967 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 7.66 | 770.25 | 1162 | 1090 | 1.0661 | 1.2724 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 10.06 | 770.25 | 1137 | 1218 | 0.9331 | 0.8013 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 10.06 | 770.25 | 1280 | 1218 | 1.0505 | 1.1545 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 12.28 | 770.25 | 1230 | 1358 | 0.9057 | 0.7719 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 12.28 | 770.25 | 1408 | 1358 | 1.0367 | 1.0901 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 14.50 | 770.25 | 1334 | 1497 | 0.8910 | 0.7731 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 14.50 | 770.25 | 1501 | 1497 | 1.0025 | 1.0052 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 16.73 | 770.25 | 1393 | 1664 | 0.8369 | 0.7040 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 16.73 | 770.25 | 1553 | 1664 | 0.9330 | 0.8791 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 18.95 | 770.25 | 1415 | 1832 | 0.7722 | 0.6264 | MN20160304_L02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 18.95 | 770.25 | 1525 | 1832 | 0.8322 | 0.7268 | MN20160304_L02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 21.17 | 770.25 | 1420 | 2008 | 0.7070 | 0.5565 | MN20160304_L02 | F07 |